Abstract
Prostate cancer continues to challenge oncologists not just by its prevalence, but by its layered biological complexity. As a disease of zones, it manifests differently depending on its anatomical origin yet this zonal nuance often fades into the background of standardized diagnostic and treatment approaches.
Historically, the spotlight has remained fixed on tumors arising from the Peripheral Zone (PZ), while the Transition Zone (TZ) a quieter, more elusive territory has been under-recognized. Emerging insights from Indian clinical practice and limited genomic datasets suggest a different truth: TZ tumors may be more prevalent in our population than previously acknowledged, and their silent nature belies the unique molecular signatures they may carry.
TZ lesions frequently appear indolent on imaging and histology, but can harbor actionable mutations or unpredictable clinical behavior. This duality calls for a new lens one that combines MRI-guided targeting, spatial transcriptomics, and deep molecular profiling to capture zone-informed cancer biology in its full complexity.
At COJ India, we believe the time is ripe to construct an Indian Zonal Molecular Atlas a collective effort to map molecular diversity across anatomical zones, refine biopsy strategies, and develop precision-guided risk models tailored to our unique clinical landscape. Such an initiative will not only align with global trends in precision oncology but serve as a cornerstone for better outcomes in Indian men.
While the current issue of COJ India is devoted to advances in Head and Neck Oncology, we now invite contributions for our next thematic issue, which will focus on urological malignancies, with a special emphasis on molecular and spatial heterogeneity in prostate cancer. We invite original research articles, insightful reviews, case series, and translational studies exploring themes such as:
Zone-specific biology of prostate cancer (Transition Zone vs. Peripheral Zone) Genomic and transcriptomic profiling in uro-oncology MRI-pathology correlation and targeted biopsy innovations Risk stratification and precision medicine in Indian cohorts
Researchers, clinicians, molecular pathologists, and imaging specialists are encouraged to contribute their work to enrich this focused issue. Together, let us shape a platform that reflects the clinical realities and scientific opportunities of uro-oncology in India.
Submissions are now open for the upcoming Uro-Oncology issue. Join us in shaping a more precise tomorrow.